Anthony O'sullivan

Anthony O'Sullivan is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical use. His work focuses on addressing metabolic disorders, showcasing his commitment to improving health outcomes.

Latest Patents

Anthony O'Sullivan holds a patent for the "Monohydrate potassium salt of a thienopyridone derivative and its preparation process." This invention relates to a process for preparing a monohydrate potassium salt of a thienopyridone derivative. It also encompasses the use of this compound in medicine, specifically for treating or preventing metabolic disorders such as NASH. He has 1 patent to his name, reflecting his innovative contributions to the field.

Career Highlights

O'Sullivan is currently employed at Poxel, a company dedicated to developing innovative treatments for metabolic diseases. His role at Poxel allows him to leverage his expertise in pharmaceutical chemistry to create impactful solutions for patients.

Collaborations

Throughout his career, Anthony has collaborated with talented professionals in the field, including Sébastien Bolze and Marc Lanz. These collaborations have further enriched his work and contributed to the advancement of pharmaceutical innovations.

Conclusion

Anthony O'Sullivan is a distinguished inventor whose work in pharmaceutical chemistry is making a difference in the treatment of metabolic disorders. His innovative spirit and dedication to research continue to drive advancements in medicine.

Profile summary based on public USPTO records.